X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-gets-usfda-nod-to-market-hiv-drug/articleshow/104159569.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.prnewswire.com/news-releases/hagens-berman-sobol-shapiro-llp-hilliard--shadowen-llp-and-durie-tangri-llp-announce-a-class-action-involving-antiretroviral-drugs-301710696.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203053
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213541
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204287
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204287
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078509
https://www.forbes.com/sites/joshuacohen/2019/08/12/antiretroviral-therapys-positive-impact-on-global-public-health-faces-challenges-moving-forward/#3e2762b32e77
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206894
https://www.raps.org/news-and-articles/news-articles/2019/5/fda-unveils-34-new-and-revised-product-specific-dr
https://www.reuters.com/article/us-indonesia-health-aids/indonesia-seeks-to-reassure-hiv-patients-over-drug-supplies-idUSKCN1P704I?feedType=RSS&feedName=healthNews
https://www.usatoday.com/story/opinion/2019/01/12/why-fda-doesnt-always-catch-tainted-medicines/2538786002/
https://www.fiercepharma.com/pharma/doj-tells-supreme-court-it-has-lost-interest-its-gilead-whistleblower-case
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091215
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091215
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203041
http://www.pharmatimes.com/news/us_approves_msd_hiv_drugs_delstrigo_and_pifeltro_1250850
https://www.biopharmadive.com/news/mercks-virology-business-needs-a-boost-it-may-not-get-that-from-2-new-hiv/531423/
https://www.biospace.com/article/is-gilead-poised-for-a-comeback-/
https://economictimes.indiatimes.com/markets/stocks/news/cipla-climbs-3-on-usfda-approval-to-hiv-drug/articleshow/64659612.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-generic-antibiotic-inhalation-solution-in-us/articleshow/64574026.cms
https://www.businesswire.com/news/home/20180509005703/en/Gilead-Lawsuits-California-HIV-Patients-File-Class
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078886
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204869
https://www.pharmacompass.com/pdf/news/krka-dd-novo-mestos-efavirenz-emtricitabine-tenofovir-disoproxil-receives-approval-in-europe-1519283024.pdf
https://www.prnewswire.com/news-releases/mylan-expands-access-to-hivaids-medicines-with-launch-of-first-generic-sustiva-tablets-300591862.html
http://www.drugstorenews.com/article/rising-pharmaceuticals-launches-generic-sustiva
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078064
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/12/news_detail_002867.jsp&mid=WC0b01ac058004d5c1
https://www.pharmacompass.com/pdf/news/mylan-sass-efavirenzemtricitabinetenofovir-disoproxil-receives-approval-in-europe-1511336134.pdf
https://www.pharmacompass.com/pdf/news/zentiva-ks-efavirenzemtricitabinetenofovir-disoproxil-zentiva-receives-approval-in-europe-1508826168.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-sustivaefavirenz-capsules-1506579138.pdf
https://www.dddmag.com/news/2017/08/mylan-launches-three-generic-antiretrovial-medicines-hiv-canada
http://www.pharmafile.com/news/514545/gilead-launch-injunction-against-mylan-and-actavis-over-hiv-generics-ireland
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207895
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204766
http://www.prnewswire.com/news-releases/mylan-receives-tentative-approval-for-tle400-under-pepfar-300426256.html
http://www.fiercepharma.com/pharma/pfizer-faces-first-2017-patent-loss-as-pristiq-generics-crash-party
http://www.bangkokpost.com/news/general/1182533/
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/more-essential-medicines-to-become-cheaper-with-nppas-latest-notification/articleshow/55375393.cms
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-shasun-gets-us-health-regulator-tentative-nod-for-hiv-treatment-drug/articleshow/52446312.cms
http://twofourinsight.com/indian-generic-manufacturer-cipla-targeting-us-hiv-market/
https://www.pharmacompass.com/pdf/news/mylan-labs-generic-efavirenz-approved-in-us-to-treat-hiv-1455879618.pdf
http://twofourinsight.com/strides-shasun-receives-positive-who-inspection-report-formulation-facility/
http://www.reuters.com/article/us-bristol-myers-m-a-gsk-idUSKBN0U10LZ20151218
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-ready-to-launch-low-dose-hiv-drug-efavirenz/articleshow/49979486.cms
Market Place
Share 
